Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(19)
MIXED(5)
Donepezil TDS
2 trials
phase_1
corium-inc
CD101 IV
2 trials
phase_1
cidara-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa
Aricept
2 trials
phase_1
corium-inc
Donepezil TDS Version E
1 trial
phase_1
corium-inc
Met DR
1 trial
phase_1_2
elcelyx-therapeutics-inc
Omeprazole
1 trial
phase_1
afferent-pharmaceuticals-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa
Donepezil TDS Version A
1 trial
phase_1
corium-inc
Donepezil TDS Version D
1 trial
phase_1
corium-inc

+13 more interventions

21 unique interventions2 categories

Analytics

Trial Phases

Phase 112
Phase 21

Trial Status

Completed12

Role Distribution

Principal Investigator12
PI Rate100%

Activity Timeline

Clinical Trials (12)

NCT05694533Phase 1Completed
Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults
Healthy
PrincipalinvestigatorStart date: 2023-03-16
NCT04060173Phase 1Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
GoutHyperuricemia
PrincipalinvestigatorStart date: 2019-09-05
NCT03453060Phase 1Completed
Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects
Thrombosis
PrincipalinvestigatorStart date: 2018-05-30
NCT03438604Phase 1Completed
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
Alzheimer's Disease
PrincipalinvestigatorStart date: 2018-02-13
NCT03259958Phase 1Completed
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
Alzheimer's Disease
PrincipalinvestigatorStart date: 2017-10-30
NCT02968719Phase 1Completed
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
Alzheimer Disease
PrincipalinvestigatorStart date: 2016-11-01
NCT02790840Phase 1Completed
A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations
Healthy
PrincipalinvestigatorStart date: 2016-05-16
NCT01804842Phase 1/2Completed
Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
Type 2 Diabetes Mellitus
Principalinvestigator
NCT02349802Phase 1Completed
Autoinjector Device Assessment Study
Healthy Subjects
Principalinvestigator
NCT02516904Phase 1Completed
A Single Ascending Dose Study of CD101 IV in Healthy Subjects
Healthy
Principalinvestigator

Showing 10 of 12 trials

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Peter Davidson, DO

Celerion

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

AstraZenecaCelerion
Collaborated on 1 trial
Similarity Score14%

Elise Hardy, MD

AstraZeneca

Related
1 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

AstraZenecaCelerion
Collaborated on 1 trial
Similarity Score14%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseDiabetes Mellitus, Type 2Gout
Similarity Score13%

General Manager

Tanabe Pharma Corporation

Related
28 trials

Shared therapeutic areas:

HealthyDiabetes Mellitus, Type 2Healthy Volunteers
Similarity Score13%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Healthy Volunteers
Similarity Score9%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

HealthyHealthy Volunteers
Similarity Score9%

Alan Kivitz, MD

Altoona Center for Clinical Research

Related
7 trials

Shared therapeutic areas:

GoutHyperuricemia
Similarity Score9%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Healthy
Similarity Score9%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

HealthyHealthy Volunteers
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

Healthy VolunteersHealthy
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT05694533Phase 1PrincipalInvestigator

Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults

Healthy
Completed
NCT04060173Phase 1PrincipalInvestigator

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671

GoutHyperuricemia
Completed
NCT03453060Phase 1PrincipalInvestigator

Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects

Thrombosis
Completed
NCT03438604Phase 1PrincipalInvestigator

A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

Alzheimer's Disease
Completed
NCT03259958Phase 1PrincipalInvestigator

A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®

Alzheimer's Disease
Completed
NCT02968719Phase 1PrincipalInvestigator

A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

Alzheimer Disease
Completed
NCT02790840Phase 1PrincipalInvestigator

A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations

Healthy
Completed
NCT01804842Phase 1/2PrincipalInvestigator

Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM

Type 2 Diabetes Mellitus
Completed
NCT02349802Phase 1PrincipalInvestigator

Autoinjector Device Assessment Study

Healthy Subjects
Completed
NCT02516904Phase 1PrincipalInvestigator

A Single Ascending Dose Study of CD101 IV in Healthy Subjects

Healthy
Completed
NCT02551549Phase 1PrincipalInvestigator

An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects

Healthy
Completed
NCT02749578Phase 1PrincipalInvestigator

Drug Interaction Study of MGL-3196 With Atorvastatin

Healthy
Completed

All 12 trials loaded